Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Chronic kidney disease
•
Nephrology
•
Endocrinology
Do you recommend stopping a SGLT2i indefinitely if a patient with chronic kidney disease and diabetes develops euglycemic diabetic ketoacidosis?
Answer from: at Academic Institution
I would. In my opinion, the risk of ketoacidosis will outweigh the possible benefit from SGLTs.
Comments
at CommonSpirit
Absolutely, I would stop SGLT as one episode shoul...
at Atrium Health Wake Forest Baptist Medical Center
I would, depending on the individual patient with ...
12214
12216
Sign in or Register to read more
22632
Related Questions
Would you stop denosumab in a patient with chronic kidney disease if they develop asymptomatic hypocalcemia after the injection?
Are recurrent UTIs a contraindication to SGLT2i use?
How do you approach managing patients with diabetic kidney disease and proteinuria who develop hypoglycemia after initiation of a SGLT2 inhibitor?
Would you recommend switching a diabetic CKD patient on oral semaglutide to the subcutaneous form since the benefits in CKD have primarily been reported in studies using subcutaneous GLP-1 receptor agonists?
Is there a role for monitoring PTH levels in patients with advanced chronic kidney disease who are receiving denosumab to assess for adynamic bone disease?
What is the role for iothalamate clearance testing for glomerular filtration estimation in patients with chronic kidney disease?
Would you consider adding an SGLT2i for a patient with proteinuric kidney disease who is already on maximal dose ACEi/ARB and has a UACR < 300 mg/g?
In which patients with non-proteinuric chronic kidney disease would you initiate a SGLT2i?
For patients with eGFR around 30, do you still consider using reclast or evenity at adjusted doses?
How do you distinguish between primary and tertiary hyperparathyroidism in a patient with ESRD?
Absolutely, I would stop SGLT as one episode shoul...
I would, depending on the individual patient with ...